BioSpace News Archive

Business

BioFluidica Taps a New CEO

January 8, 2016
·
2 min read
Drug Development

AcelRx Completes Protocol Review With FDA And Plans To Initiate Phase 3 Open-Label Study (IAP312) For Zalviso In 1Q 2016

January 8, 2016
·
5 min read
Drug Development

PTC Therapeutics Completes Rolling NDA Submission To FDA And Submits Phase 3 ACT DMD Clinical Trial Results To European Medicines Agency for Translarna (ataluren) For Treatment Of Nonsense Mutation Duchenne Muscular Dystrophy

January 8, 2016
·
7 min read
Drug Development

Regeneron And Sanofi Announce Sarilumab Biologics License Application Accepted For Review By US FDA

January 8, 2016
·
8 min read
Biotech Beach

ImpediMed Inc. Announces U.S. Commercial Launch Of L-Dex System For Assessment Of Lymphedema In Cancer Survivors

January 8, 2016
·
4 min read
Biotech Bay

Ardelyx Announces Pricing Of Public Offering Of Common Stock

January 8, 2016
·
4 min read
WuXi AppTec Plans $120 Million Investment In New Integrated Biologics Solution Center To Expedite Biologics Development From Ideas To Clinic

January 8, 2016
·
2 min read
Drug Development

Protagonist Therapeutics Initiates Phase 1 Study With Oral Peptide PTG-100

January 8, 2016
·
2 min read
Business

Mirati Therapeutics Appoints Marcy Graham Vice President, Investor Relations And Corporate Communications

January 8, 2016
·
4 min read
Biotech Bay

Finesse Solutions Launches TruBio DV 5.0 Bioreactor Control Software With New User Interface And Deltav Batch S88 Capability

January 8, 2016
·
2 min read